Rifampicin CAS:13292-46-1 99% ʻAlani i ka pauka ʻulaʻula/ʻeleʻele
| Helu Helu | XD90358 |
| inoa mea kūʻai | Rifampicin |
| CAS | 13292-46-1 |
| ʻĀpana Molekala | C43H58N4O12 |
| Kaumaha Molecular | 822.94 |
| Nā kikoʻī mālama | -15 a -20 °C |
| Kānāwai Kūʻai Kūlike | 29419000 |
Huahana Huahana
| pH | 4.5-6.5 |
| Hoʻāʻo | 99% |
| Ka nana aku | ʻAlani a ʻulaʻula/ʻulaʻula pauda |
| Nalo ma ka maloo | 1.0% kiʻekiʻe |
| Lehu Sulphated | 1.0% kiʻekiʻe |
No ka noiʻi ʻana a hoʻohālikelike i ka ʻōlelo o recA a me recX, nā ʻāpana o ke ala SOS, ma hope o ka mālama ʻana i ka rifampicin i nā lāʻau lapaʻau-susceptible a me MDR maʻi maʻi o Mycobacterium tuberculosis. koʻikoʻi no 36 mau hola ma hope o ka unuhi ʻana o RNA.ʻO ka recA a me ka recX i loko o ka RNA extract ua manaʻo ʻia me ka hoʻohana ʻana i ka qRT-PCR. ʻO ka MDR clinical strain i hoʻokomo ʻia i ka wikiwiki (24 mau hola) a ʻoi aku ka kiʻekiʻe (7-fold) o ka recA i hoʻohālikelike ʻia me ka lāʻau-susceptible strain (36 h) i ka pane ʻana i ka rifampicin .Ua ʻike ʻia ka piʻi ʻana o nā pae recX me ka piʻi ʻana o nā pae o recA;akā naʻe, ua ʻoi aku ka kiʻekiʻe o nā pae ma mua o ka recA.Drug-susceptible and MDR strains he mau kinetics like ʻole o ka hoʻokomo ʻana i ka hoʻoponopono DNA.© The Author 2014. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy.
